ACTRN12616001689460进行中（未招募）未知
A pragmatic, multicentre, single-blinded, parallel-group, randomised controlled trial to determine the effect of mobile phone text messaging intervention on blood pressure for patients with diabetes and cardiovascular diseases.-SupportMe
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 907
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients will be 18 years or older, provide informed consent, be referred by a clinician in the WSLHD and meet all of the following:
- •a)At least one of the following clinical criteria:
- •1. Coronary heart disease (CHD) defined as documented prior myocardial infarction, coronary artery bypass graft surgery, percutaneous coronary intervention, or 50% or greater stenosis in at least 1 major epicardial vessel on coronary angiography.
- •2. Type 2 Diabetes as diagnosed by a physician with an HbA1C greater than 7.o% and less than or equal to 11.0%
- •b)Own a mobile phone
- •c)Read text messages in English or one of the limited number of languages that we will provide in the program
排除标准
- •a.Unable to complete the study procedures and/or follow-up
- •b.Any condition that in the opinion of the responsible physician or investigator that renders the patient unsuitable for the study (e.g. severe disability or significant memory or behavioural disorder)
研究者
相似试验
尚未招募
3 期
Reduction assessment of cold or flu symptoms with Fluviral® compared to Resfenol®, in adult participantsFlu, Commom Cold.C02.782.687.207C02.782.620.375RBR-3p4npxHospital das Clínicas de Porto Alegre
招募中
不适用
A prospective, multicenter, parallel, single-blind, randomized, pivotal study to evaluate the safety and efficacy of the everolimus eluting bioresorbable stent ‘BRSTM’ compared to 'XIENCETM' stent in patients with de novo coronary artery lesions.KCT0005960Dotter128
未知
2 期
Kagami/SDS ProjectGastrointestinal Endoscopic Tests (Including Endoscopic Polypectomy)JPRN-jRCT2080221299AstraZeneca
已完成
2 期
A clinical study to evaluate efficacy of a copper containing intrauterine device (Coated Copper- T) in reducing bleeding side effects.CTRI/2016/01/006535HLL Lifecare Limited176
已完成
3 期
A Phase III clinical study to compare efficacy and safety of Efonidipine and Telmisartan combination when compared to Cilnidipine and Telmisartan combination in patients with Stage II hypertension.CTRI/2020/12/029739Zuventus Healthcare Limited240